Christine Fritsch,Christian Chatenay-Rivauday,Johannes Roesel,Markus Wartmann,Diana Graus Porta
申请号：
US14892082
公开号：
US20160095842A1
申请日:
2014.05.28
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A pharmaceutical combination comprising an alpha-isoform specific phosphatidylinositol 3-kinase inhibitor compound of formula (I) or a pharmaceutically acceptable salt thereof and a fibroblast growth factor receptor (FGFR) kinase inhibitor, particularly for simultaneous, separate or sequential use for the treatment of a cancer use of such pharmaceutical combination for the preparation of a medicament for the treatment of a cancer use of such pharmaceutical combination for the treatment a cancer a method for treating a cancer comprising administering to a subject having said cancer a jointly therapeutically effective amount of such combination and related pharmaceutical compositions or kits thereof.
